For example, PME-1 overexpression is commonly observed in brain samples from patients with tauopathies, such as progressive supranuclear palsy (PSP) and Alzheimer’s disease (AD) [58]. Here, PPME1 is linked to early-onset autosomal dominant Alzheimer disease.